MTS Medication Technologies (MTSI) Reaffirms FY09 Outlook
More News related to MTSI
- Notable Mergers and Acquisitions of the Day 8/10: MSFT, MIL, MTSI, WEBM
- MTS Medication (MTSI) Agrees To Be Acquired For $5.75/Share
- MTS Medication Tech. (MTSI) Tops Q4 Views
- MTS Medication Tech. (MTSI) Reports Q3 Earnings
- MTS Medication Technologies (MTSI) Reaffirms FY09 Outlook
MTS Medication Technologies, Inc. (Nasdaq: MTSI) expects to reaffirm its FY09 guidance for sales in the range of $75-$78 million and EPS in the range of $0.35-$0.40. The Street estimates are for sales of $76.20 million and EPS of $0.36. (only 1 analyst covers the stock)
MTS Medication Technologies, Inc., through its subsidiaries, manufactures and sells consumable medication punch cards, packaging equipment, and ancillary products in the United States, Canada, and Europe.
Related Categories
GuidanceStocks Mentioned
+0.01Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
